UBS Group’s BioVie BIVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
122,192
+72,381
| +145% | +$67K | ﹤0.01% | 5870 |
|
|
2025
Q1 | $48.8K | Buy |
49,811
+1,484
| +3% | +$1.45K | ﹤0.01% | 6324 |
|
|
2024
Q4 | $96.7K | Buy |
48,327
+48,282
| +107,293% | +$96.6K | ﹤0.01% | 5680 |
|
|
2024
Q3 | $54 | Sell |
45
-414
| -90% | -$497 | ﹤0.01% | 8009 |
|
|
2024
Q2 | $184 | Sell |
459
-21,931
| -98% | -$8.79K | ﹤0.01% | 7923 |
|
|
2024
Q1 | $11.8K | Buy |
22,390
+8,934
| +66% | +$4.73K | ﹤0.01% | 5992 |
|
|
2023
Q4 | $17K | Buy |
13,456
+10,056
| +296% | +$12.7K | ﹤0.01% | 5999 |
|
|
2023
Q3 | $11.6K | Sell |
3,400
-1,470
| -30% | -$5.01K | ﹤0.01% | 5912 |
|
|
2023
Q2 | $21K | Buy |
4,870
+1,470
| +43% | +$6.34K | ﹤0.01% | 5774 |
|
|
2023
Q1 | $27.5K | Sell |
3,400
-165
| -5% | -$1.33K | ﹤0.01% | 5760 |
|
|
2022
Q4 | $27.7K | Buy |
3,565
+2,637
| +284% | +$20.5K | ﹤0.01% | 6151 |
|
|
2022
Q3 | $2K | Buy |
928
+671
| +261% | +$1.45K | ﹤0.01% | 8587 |
|
|
2022
Q2 | $0 | Sell |
257
-1,852
| -88% | – | ﹤0.01% | 9249 |
|
|
2022
Q1 | $10K | Sell |
2,109
-12
| -0.6% | -$57 | ﹤0.01% | 7339 |
|
|
2021
Q4 | $10K | Buy |
2,121
+2,031
| +2,257% | +$9.58K | ﹤0.01% | 7636 |
|
|
2021
Q3 | $1K | Sell |
90
-1,779
| -95% | -$19.8K | ﹤0.01% | 7984 |
|
|
2021
Q2 | $32K | Buy |
+1,869
| New | +$32K | ﹤0.01% | 5768 |
|